Skip to search formSkip to main contentSkip to account menu

Hypercalcemia

Known as: CALCIUM BLOOD INCREASED, Hypercalcemia [Disease/Finding], High blood calcium levels 
Higher than normal levels of calcium in the blood. Some types of cancer increase the risk of hypercalcemia.
National Institutes of Health

Related topics

Related topics

49 relations
10 ML Pamidronate Disodium 3 MG/ML Injection10 ML Pamidronate Disodium 9 MG/ML Injection100 ML zoledronic acid 0.05 MG/ML Injection5 ML zoledronic acid 0.8 MG/ML Injection

Narrower (4)

Blue diaper syndromeHYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II (disorder)Humoral hypercalcemia of malignancy (disorder)SHORT syndrome

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2000
Review
2000
The probable involvement of soluble and deposited melanins, their intermediates and the reactive oxygen side-products in human diseases and aging.
Highly Cited
1991
Highly Cited
1991
A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.
Although 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] has been shown to inhibit the growth of certain malignant cells, its… 
Highly Cited
1987
Highly Cited
1987
Treatment of skeletal disease in breast cancer: a controlled clodronate trial.
Normocalcaemic breast cancer patients with progressive osteolytic bone metastases were treated with clodronate 1.6 g/day (17) or… 
Highly Cited
1985
Highly Cited
1985
Vitamin D metabolism in patients intoxicated with ergocalciferol.
Vitamin D metabolites were measured on admission in eight patients intoxicated with ergocalciferol (serum calcium 3.01-4.05 mmol… 
Highly Cited
1982
Highly Cited
1982
TREATMENT OF POST MENOPAUSAL OSTEOPOROSIS. A CONTROLLED THERAPEUTIC TRIAL COMPARING OESTROGEN/GESTAGEN, 1,25‐DIHYDROXY‐VITAMIN D3 AND CALCIUM
A controlled therapeutic trial on seventy‐four 70‐year‐old women was carried out with the purpose of finding the optimal… 
Highly Cited
1977
Highly Cited
1977
Effect of prostaglandin endoperoxides and metabolites on bone resorption in vitro
PROSTAGLANDINS are potent bone resorbers1 which have been implicated as mediators of bone loss and hypercalcaemia in disease2–6… 
Highly Cited
1976
Highly Cited
1976
BREAST-CANCER OSTEOLYSIS, BONE METASTASES, AND ANTI-OSTEOLYTIC EFFECT OF ASPIRIN
Review
1974
Review
1974
Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma.
A case is reported of a man who experienced hypercalcemia as a result of developing liver and renal-cell cancer. Repeated… 
Highly Cited
1973
Highly Cited
1973
Neonatal parathyroid function: role of gestational age and postnatal age.
Highly Cited
1971
Highly Cited
1971
Immunoassay for human calcitonin. II. Clinical studies.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)